India to Philippines: Domperidone Export Trade Route

The India to Philippines Domperidone corridor is one of India's established pharmaceutical export routes, with 129 shipments documented worth a combined $2.3M USD. The route is dominated by FORTCAPS LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 30% of all export value, reflecting the consolidated nature of India's domperidone manufacturing sector.

Across 31 active suppliers, the average shipment value stands at $18.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with domperidone's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 14.5%, placing it at rank #11 among India's top domperidone export destinations globally.

On the import side, key buyers of Indian domperidone in Philippines include OLLEN PHARMA TRADING INC, TO THE ORDER OF, NA and 31 others. OLLEN PHARMA TRADING INC is the single largest importer with 7 shipments valued at $1.0M USD.

India's domperidone exports to Philippines are driven primarily by a handful of large-scale manufacturers. FORTCAPS LABORATORIES PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 31 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FORTCAPS LABORATORIES PRIVATE LIMITED, BDH INDUSTRIES LIMITED, CONCEPT PHARMACEUTICALS LIMITED — together account for 48% of total trade value on this route. The average shipment value of $18.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products harmless medicine, pantozisaph pantoprazole + domperidone capsules 40 mg / 30 mg and pharmacuticals products for human consumption export only pantec-dsr pantoprazole (as sodium sesquihydrate)+domperidone, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, OLLEN PHARMA TRADING INC is the largest importer with 7 shipments worth $1.0M USD — representing 43% of all domperidone imports from India on this route. A total of 34 buyers are active on this corridor.